Novo Nordisk and Biomarin make peace in strife over employees and confidentiality

Novo Nordisk and the US-based biotech firm Biomarin have settled their court fight in the battle for the hemophilia market, according to Danish newspaper Børsen.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app